Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG plus lateral femoral cutaneous nerve block with levobupivacaine versus ropivacaine for pain control in elderly hip fracture surgery
2020-004697-21Phase 4Completed
- Sponsor
- Hospital Universitario de Salamanca
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hip fracture comparing Levobupivacaine arm with Ropivacaine arm (2 arms). Primary endpoint: Complications during surgery invalidating study results. Started Oct 2020; status: completed.
02
Drugs
levobupivacaineropivacaine
03
Conditions
hip fracture
Beyond the preview
Go deeper on 2020-004697-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004697-21.